There is an old saying that ridiculously overvalued shares can get even more ridiculously overvalued. Competitive markets may be perfect (the theory that public knowledge permeates every corner of the public domain) but those who buy and sell shares know they are far from perfect in the everyday meaning of the word. Greggs which was…
Barclays Bank (BARC) saw a 60% fall in underlying earnings in the year to 31st December 2013, which was modestly and partly recovered with a 13% increase in earnings last year to 31st December 2014. The company has recently produced its Q1 results to 31st March 2015. So what do they tell us about its…
The first quarter results and statement from GSK has a biblical flavour. We are exalted to raise our gaze unto the hills from which cometh our salvation; which the regulators less poetically translate as future and forward statements. It was an occasion for a transcendental gazing into the future because the Q1 results were not…
Technically interesting perhaps but still very highly price on near term earnings estimates. My last words on this magnificently highly valued share (the share price was then 3,088p) amounted to a question: “A chart worth inspection; a potential momentum buy?” Well now we know the answer! There was momentum but as it turned out, it…
It was a mere fifty days or so ago – yes, as little time as that – when I last looked, mesmerised, into the captivating gaze of pure speculation; the eyes of the cobra. I refer of course to my late February views on Ladbrokes (LAD), the once proud owners of Hilton Hotels, now reduced…
BP’s first quarter results come from a rather battered company that looks (in my imagination) a bit like one of those destroyers returning to port at early dawn, having encountered Captain Lansdorff’s pocket battleship the “Admiral Graff Spee”, at the mouth of the River Plate all those years ago. Its superstructure is in a sorry…
The International Consolidated Airlines (IAG) share price has turned south in recent weeks but is still showing on the radar as being within the flight path fluctuations around the powerful share price up-trend. There is potential trend support just below the current share price (have a look). Will it bounce there, to continue the established…
Everyone has heard the bad news but what does it mean and how much of it has been discounted by the recent share price from the low of 155p? The biggest item to be seen in the last set of preliminary figures reported by the company for the year to February 2015 is the exceptional…
GlaxoSmithKline: a share supported by a good yield, a potential special shareholder return and potentially supportive news flow. When I first started to put pen to paper on this pre-trading statement appreciation of GlaxoSmithKline, the share price was 1626. In terms of years, Shakespeare was dead and buried by 1626. The share price now, as…
In my recent musings about the relative charms of BP (BP.) and Shell (RDSB) equity, I concluded that I preferred BP because Royal Dutch could make a bid for BP. Earlier this week, Royal Dutch Shell blew that bit of rationalisation out of the deep blue waters of speculation, by saying that it was to…
